A Double-Blind, Randomised, Placebo-Controlled Phase I/IIa Study to Investigate the Safety, Tolerability and Efficacy on Pain of Intra-Articular ESBA105 Applied to Patients With Severely Painful Osteoarthritis of the Knee.
Phase of Trial: Phase I/II
Latest Information Update: 11 Apr 2013
At a glance
- Drugs DLX 105 (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- 23 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Mar 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 May 2009 Additional location (Germany) identified as reported by ClinicalTrials.gov.